share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

辉瑞 | 4:持股变动声明-高管 BOURLA ALBERT
美股SEC公告 ·  12/03 05:21

Moomoo AI 已提取核心信息

Albert Bourla, Chairman & CEO of Pfizer, reported no stock transactions as of 11/29/2024. The announcement indicates that there were no non-derivative securities transactions recorded for this period.This report is part of the regular disclosure requirements for executives, ensuring transparency in stock dealings. The absence of transactions suggests no recent changes in Bourla's stock holdings in Pfizer.Investors should note that while no transactions were reported, this does not necessarily imply future actions or intentions regarding stock holdings. The report serves as a compliance measure, reflecting the current status of stock transactions by the CEO.
Albert Bourla, Chairman & CEO of Pfizer, reported no stock transactions as of 11/29/2024. The announcement indicates that there were no non-derivative securities transactions recorded for this period.This report is part of the regular disclosure requirements for executives, ensuring transparency in stock dealings. The absence of transactions suggests no recent changes in Bourla's stock holdings in Pfizer.Investors should note that while no transactions were reported, this does not necessarily imply future actions or intentions regarding stock holdings. The report serves as a compliance measure, reflecting the current status of stock transactions by the CEO.
辉瑞董事长兼首席执行官阿尔伯特·布拉截至2024年11月29日没有报告任何股票交易。该公告表明,在此期间没有记录非衍生证券交易。该报告是高管定期披露要求的一部分,旨在确保股票交易的透明度。没有交易表明布拉在辉瑞的股票持有量最近没有变化。投资者应注意,尽管没有报告任何交易,但这并不一定意味着未来有关股票持有的行动或意图。该报告是一项合规措施,反映了首席执行官股票交易的现状。
辉瑞董事长兼首席执行官阿尔伯特·布拉截至2024年11月29日没有报告任何股票交易。该公告表明,在此期间没有记录非衍生证券交易。该报告是高管定期披露要求的一部分,旨在确保股票交易的透明度。没有交易表明布拉在辉瑞的股票持有量最近没有变化。投资者应注意,尽管没有报告任何交易,但这并不一定意味着未来有关股票持有的行动或意图。该报告是一项合规措施,反映了首席执行官股票交易的现状。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息